Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase <i>Ptpn11</i> (Shp2) on malignant transformation of hematopoietic cellsDan Xu, Cheng‐Kui Qu|The Journal of Experimental Medicine|2011Cited by 111
Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer TreatmentLubing Gu, Muxiang Zhou, Tao Liu et al.|Cancer Cell|2016Cited by 85
Effects of a Leukemia-associated Gain-of-Function Mutation of SHP-2 Phosphatase on Interleukin-3 SignalingWen-Mei Yu, Cheng‐Kui Qu|Journal of Biological Chemistry|2005Cited by 50
SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-AblJing Chen, Cheng‐Kui Qu|Blood|2006Cited by 43
Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and AngiogenesisSiying Wang, Cheng‐Kui Qu|Journal of Biological Chemistry|2008Cited by 37